Vestal Point Capital »

Anteris Technologies Global shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Anteris Technologies Global (AVR) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Anteris Technologies Global

Tip: Access up to 7 years of quarterly data

All positions including Anteris Technologies Global held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anteris Technologies Global by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.4M 1.1M 5.55

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding Anteris Technologies Global

Nantahala Capital Management
BlackRock
ADAR1 Capital Management
Perceptive Advisors
RA Capital Management
BVF
L1 Capital Pty
Ensign Peak Advisors
Sio Capital Management
Geode Capital Management
Rhenman & Partners Asset Management AB
UBS Group
Vestal Point Capital
Vanguard Capital Management
Suvretta Capital Management

View all funds holding Anteris Technologies Global